drugset
drugset / Trial / NCT07281781

Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

NCT07281781 ↗

Phase 1/2 Recruiting 10 enrolled University of California, Irvine
NaSingle-groupOpen-labelTreatment

Summary

This is a phase I/II protocol investigating whether Nelfinavir can improve anemia and lower serum fibrosis biomarkers in Myelofibrosis patients.

Timeline

Start
2025-09-16
Primary completion
2026-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nelfinavir Other / unclassified — Oral

Indications

myelofibrosis